This inventor holds 1 USPTO granted patent. Top assignees: Guangdong Ocean University, Shenzhen Institute of Guangdong Ocean University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Zhiyou Yang in Neuroinflammation Prevention
Introduction
Zhiyou Yang is a notable inventor based in Zhanjiang, China. He has made significant contributions to the field of medicine, particularly in the prevention of neuroinflammation and cognitive disorders. His innovative work has the potential to impact clinical practices and improve patient outcomes.
Latest Patents
Zhiyou Yang holds a patent for the "Applications of butyrolactone-I in preparing medicine for preventing neuroinflammation and/or memory and cognitive disorders." This patent outlines the use of butyrolactone-I in the preparation of medicine aimed at preventing aluminum-induced neuroinflammation and cognitive disorders in zebrafish. The findings suggest that butyrolactone-I may prevent neuroinflammation and enhance memory and cognitive function through mechanisms such as antioxidation, inhibition of acetylcholinesterase activity, anti-inflammation, and regulation of intestinal flora disorder. This research provides a feasible approach for preventing neurodegenerative diseases in clinical medicine.
Career Highlights
Zhiyou Yang has worked at prominent institutions, including Guangdong Ocean University and the Shenzhen Institute of Guangdong Ocean University. His research has focused on the intersection of neurobiology and pharmacology, leading to innovative solutions for complex medical challenges.
Collaborations
Zhiyou Yang has collaborated with notable colleagues, including Yi Zhang and Yingying Nie. Their joint efforts have contributed to advancing research in neuroinflammation and cognitive disorders.
Conclusion
Zhiyou Yang's innovative work in the field of neuroinflammation prevention showcases his dedication to improving medical treatments. His patent on butyrolactone-I highlights the potential for new therapeutic approaches in addressing cognitive disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile